During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome. In the Journal of Neurology, Rohit Bakshi, MD, a senior neurologist at Brigham and Women’s Hospital, and international co-authors present the cases...
Tag: <span>Neurology</span>
Post
Blood sample can be used to assess the severity and prognosis of frontotemporal lobar degeneration in the future
by University of Eastern Finland Biomarkers to support the diagnosis of frontotemporal lobar degeneration (FTLD) and to assess the severity and expected prognosis of the disease are needed. Neurofilament light chain (NfL) measured from a blood sample strongly correlates with the duration of the disease in FTLD patients and the rate of brain atrophy, according...
Post
How the brain controls our speech
by Goethe University Frankfurt am Main Speaking requires both sides of the brain. Each hemisphere takes over a part of the complex task of forming sounds, modulating the voice and monitoring what has been said. However, the distribution of tasks is different than has been thought up to now, as an interdisciplinary team of neuroscientists...
Post
Social isolation increases the risk of heart attacks, strokes, and death from all causes
by European Academy of Neurology Those who are socially isolated are over 40% more likely to have a cardiovascular event, such as a heart attack or stroke, than those who were socially integrated, new research has shown. The German study, due to presented tomorrow at the European Academy of Neurology (EAN) Virtual Congress, found that...
Post
Biomarkers may help us understand recovery time after concussion
by American Academy of Neurology A blood test may help researchers understand which people may take years to recover from concussion, according to a study published in the May 27, 2020 online issue of Neurology, the medical journal of the American Academy of Neurology. The study looked at a biomarker called neurofilament light chain, a...
Post
Researchers discover biomarkers of ALS in teeth
New York, NY (May 21, 2020)–Mount Sinai scientists have identified biological markers present in childhood that relate to the degenerative and often fatal neurological disease called amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease, according to a study published in the Annals of Clinical and Translational Neurology in May. (https://www.youtube.com/watch?v=Bw-_XUZssMM&feature=youtu.be) The researchers...
Post
Researchers link high calcium levels in mitochondria to neuronal death in Alzheimer’s disease
by Brian Burns, Massachusetts General Hospital For the first time, using a mouse model of Alzheimer’s disease, scientists have documented a link between raised levels of calcium in mitochondria and neuronal death in the living brain. This relationship was previously documented in cell culture, but seeing this phenomenon in living mice makes it more likely...
Post
Predictive models could provide more accurate detection of early-stage Parkinson’s disease
by York University How is your sense of smell? Do you find yourself frequently dozing off during the day or thrashing about during dreams? Often, early stage Parkinson’s disease does not present with typical motor disturbance symptoms, making diagnosis problematic. Now, neuroscientists at York University have found five different models that use these types of...
Post
New blood test for Alzheimer’s developed
by Margareta G. Kubista, University of Gothenburg A new blood test for Alzheimer’s disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, which makes the test relatively simple and cheap to perform. The research...
Post
FDA approves first drug to help tame cluster headaches
Episodic cluster headaches are “an extremely painful and often debilitating condition,” the FDA’s Dr. Eric Bastings noted in an agency news release. He’s deputy director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research. Cluster headaches occur in quick sequence, “often at the same time(s) of the day, for several weeks...